|Mr. Carl A. Merton||Chief Financial Officer||319.2k||N/A||N/A|
|Ms. Megan McCrae||Director of Marketing||197.65k||N/A||N/A|
|Mr. Irwin D. Simon||Interim CEO & Independent Chairman||N/A||N/A||N/A|
|Mr. Jakob Ripshtein||Pres||N/A||N/A||N/A|
|Mr. Gary Leong||Chief Science Officer||N/A||N/A||1965|
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.
Aphria Inc.’s ISS Governance QualityScore as of April 1, 2019 is 8. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 6; Compensation: 9.